Moody’s assigns ‘Baa3’ rating to OU Medicine’s bonds

Moody’s Investors Service assigned its “Baa3” rating to Oklahoma City-based OU Medicine’s proposed $1 billion series 2018B and $251 million series 2018C revenue bonds.

Advertisement

The assignment is a result of several factors, including OU Medicine’s favorable market position, close ties with the University of Oklahoma, healthy cashflow margins and a strong management team that Moody’s expects will effectively lead the system through the transition to a nonprofit healthcare system.  Moody’s also acknowledged the health system’s increasingly competitive market, high leverage metrics, modest liquidity and high reliance on Medicaid and self-pay payers.

The outlook is stable, reflecting Moody’s expectation that OU Medicine will maintain strong margins during the transition period because of the tenured management team and well-planned transition strategy.

More articles on healthcare finance:
Donations to USC medical school fall 55% after dean, faculty scandals
U of Texas Health renames cancer center after donors of $25M gift
10 recent hospital, health system outlook and credit rating actions

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.